majority of shareholders in AmerisourceBergen (ABC), one of the largest pharmaceutical wholesalers, rejected a proposal that would have required the company to report steps taken to manage the financial and reputational risks associated with the opioid crisis.

However, when subtracting shares held by insiders, including the Walgreen pharmacy chain that owns 26 percent of the stock, the proposal resonated widely. Sixty-two percent of independent shareholders voted in favor, according to Investors for Opioid Accountability, a coalition of socially minded institutional investors that submitted the proposal.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

  • It is extremely unfair to the American public that suffer from pain. I have a lateral hip tear with severe arthritis in my hip also. It is impossible for me to obtain pain relief, due to this crisis. Focus on the heroin getting into the country. Don’t force Americans to suffer who need it. Focus on bogus doctors. Don’t make the American public suffer in pain!!

Recommended Stories

Pharmaceutical production
Drug Pricing

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.